Delivery Order SPE2DB22D3401-SPE2DB25FT3JT

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,567,202,673 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $5,044.30. The contract has a firm fixed price and a completion date of February 10, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,563,519,182 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a total ceiling value of $2,564.45. The contract is a firm fixed-price delivery order with a period of performance through February 2, 2024. This award is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,519.20, is for the supply of 4,568,062,424 units of the vaccine Typhim VI 25 MCG/0.5 ML SYRNG 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows AmerisourceBergen to provide a wide range of pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The award has a ceiling value of $1,317.41 and a completion date of May 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $39,739.00 firm-fixed-price contract is for the supply of 4565427538 units of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,563,369,034 units of the Typhim VI vaccine (25 mcg/0.5 mL vial, 10 mL). The contract has a ceiling value of $12,172.03 and a period of performance through January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a $3,939.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,549,323 units of the Typhim VI 25 mcg/0.5 mL vaccine. The contract has an ultimate completion date of August 23, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,176 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a ceiling value of $37,452.40 and a period of performance through April 8, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,342,095 units of the Typhim VI 25 MCG/0.5 ML vaccine, with a ceiling value of $17,208.40. The contract type is firm fixed price, and the ultimate completion date is June 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567080890 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, with a firm fixed price ceiling value of $10,359.48 and a period of performance through January 30, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3JT
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,072,753 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $8,413.49 and a period of performance ending on April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not designated as a set-aside.

Generated 7/29/25, 10:02 AM